KR20240004276A - 아데노신 데아미나아제 변이체 및 이의 용도 - Google Patents
아데노신 데아미나아제 변이체 및 이의 용도 Download PDFInfo
- Publication number
- KR20240004276A KR20240004276A KR1020237033780A KR20237033780A KR20240004276A KR 20240004276 A KR20240004276 A KR 20240004276A KR 1020237033780 A KR1020237033780 A KR 1020237033780A KR 20237033780 A KR20237033780 A KR 20237033780A KR 20240004276 A KR20240004276 A KR 20240004276A
- Authority
- KR
- South Korea
- Prior art keywords
- adenosine deaminase
- variant
- amino acid
- base editor
- editing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/04—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amidines (3.5.4)
- C12Y305/04004—Adenosine deaminase (3.5.4.4)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/04—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amidines (3.5.4)
- C12Y305/04005—Cytidine deaminase (3.5.4.5)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Crystallography & Structural Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163166778P | 2021-03-26 | 2021-03-26 | |
| US63/166,778 | 2021-03-26 | ||
| US202163229057P | 2021-08-03 | 2021-08-03 | |
| US63/229,057 | 2021-08-03 | ||
| PCT/US2022/022050 WO2022204574A1 (en) | 2021-03-26 | 2022-03-25 | Adenosine deaminase variants and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20240004276A true KR20240004276A (ko) | 2024-01-11 |
Family
ID=83397962
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020237033780A Pending KR20240004276A (ko) | 2021-03-26 | 2022-03-25 | 아데노신 데아미나아제 변이체 및 이의 용도 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240158775A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4313118A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024511163A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240004276A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022246176A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023019539A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3214494A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022204574A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3850088A4 (en) | 2018-09-07 | 2023-07-19 | Beam Therapeutics, Inc. | Compositions and methods for improving base editing |
| KR20210055733A (ko) | 2018-09-07 | 2021-05-17 | 빔 테라퓨틱스, 인크. | 핵염기 편집 시스템을 전달하기 위한 조성물 및 방법 |
| JP7646552B2 (ja) | 2019-01-31 | 2025-03-17 | ビーム セラピューティクス インク. | 低減された非標的脱アミノ化を有する核酸塩基エディターおよび核酸塩基エディターの特徴づけのためのアッセイ |
| US12600971B2 (en) | 2019-02-13 | 2026-04-14 | Beam Therapeutics Inc. | Modified immune cells having adenosine deaminase base editors for modifying a nucleobase in a target sequence |
| WO2020168135A1 (en) | 2019-02-13 | 2020-08-20 | Beam Therapeutics Inc. | Compositions and methods for treating alpha-1 antitrypsin deficiency |
| US12594301B2 (en) | 2019-09-27 | 2026-04-07 | Beam Therapeutics Inc. | Compositions and methods for treatment of liquid cancers |
| AU2021347359A1 (en) | 2020-09-25 | 2023-05-18 | Beam Therapeutics Inc. | Fratricide resistant modified immune cells and methods of using the same |
| EP4458963A1 (en) * | 2023-05-04 | 2024-11-06 | Technische Universität Dresden | Highly active crispr base editors obtained through cas-assisted substrate-linked directed evolution (caslide) |
| WO2024227911A2 (en) * | 2023-05-04 | 2024-11-07 | Technische Universität Dresden | Highly active crispr base editors obtained through cas-assisted substrate-linked directed evolution (caslide) |
| CN120290534A (zh) * | 2024-01-10 | 2025-07-11 | 上海数因信科智能科技有限公司 | 腺嘌呤脱氨酶、包含其的碱基编辑器融合蛋白和碱基编辑器系统及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015332533B2 (en) * | 2014-10-14 | 2018-08-30 | Halozyme, Inc. | Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same |
| AU2020216484A1 (en) * | 2019-01-31 | 2021-07-29 | Beam Therapeutics Inc. | Nucleobase editors having reduced off-target deamination and methods of using same to modify a nucleobase target sequence |
| JP7646552B2 (ja) * | 2019-01-31 | 2025-03-17 | ビーム セラピューティクス インク. | 低減された非標的脱アミノ化を有する核酸塩基エディターおよび核酸塩基エディターの特徴づけのためのアッセイ |
| AU2020322021A1 (en) * | 2019-07-30 | 2022-02-10 | Pairwise Plants Services, Inc. | Morphogenic regulators and methods of using the same |
| US20220290121A1 (en) * | 2019-08-30 | 2022-09-15 | The General Hospital Corporation | Combinatorial Adenine and Cytosine DNA Base Editors |
| AU2020344547A1 (en) * | 2019-09-09 | 2022-03-24 | Beam Therapeutics Inc. | Novel nucleobase editors and methods of using same |
-
2022
- 2022-03-25 BR BR112023019539A patent/BR112023019539A2/pt unknown
- 2022-03-25 WO PCT/US2022/022050 patent/WO2022204574A1/en not_active Ceased
- 2022-03-25 CA CA3214494A patent/CA3214494A1/en active Pending
- 2022-03-25 EP EP22776767.0A patent/EP4313118A4/en active Pending
- 2022-03-25 JP JP2023558765A patent/JP2024511163A/ja active Pending
- 2022-03-25 AU AU2022246176A patent/AU2022246176A1/en active Pending
- 2022-03-25 KR KR1020237033780A patent/KR20240004276A/ko active Pending
-
2023
- 2023-09-26 US US18/474,969 patent/US20240158775A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20240158775A1 (en) | 2024-05-16 |
| JP2024511163A (ja) | 2024-03-12 |
| WO2022204574A1 (en) | 2022-09-29 |
| BR112023019539A2 (pt) | 2023-12-05 |
| EP4313118A1 (en) | 2024-02-07 |
| CA3214494A1 (en) | 2022-09-29 |
| EP4313118A4 (en) | 2025-06-18 |
| AU2022246176A1 (en) | 2023-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102852347B1 (ko) | 프로그래밍가능한 염기 편집기 시스템을 이용하여 병원성 아미노산을 치환하는 방법 | |
| KR20210055733A (ko) | 핵염기 편집 시스템을 전달하기 위한 조성물 및 방법 | |
| AU2019282149B2 (en) | RNA-guided nucleases and active fragments and variants thereof and methods of use | |
| CN120005859B (zh) | 治疗血红素病变的组合物和方法 | |
| JP7646552B2 (ja) | 低減された非標的脱アミノ化を有する核酸塩基エディターおよび核酸塩基エディターの特徴づけのためのアッセイ | |
| KR102959498B1 (ko) | 프로그래밍가능한 염기 편집기 시스템을 이용하여 단일염기다형성을 편집하는 방법 | |
| JP7418470B2 (ja) | オリジアス由来のトランスポザーゼを用いた核酸コンストラクトの真核細胞への組み込み | |
| KR102827276B1 (ko) | 아데노신 핵염기 편집제 및 그의 용도 | |
| KR102959497B1 (ko) | 프로그래밍가능한 염기 편집기 시스템을 이용하여 병원성 돌연변이를 억제하는 방법 | |
| JP7418469B2 (ja) | アミエロイス由来のトランスポザーゼを用いた核酸コンストラクトの真核生物のゲノムへの転移 | |
| KR20230014700A (ko) | Rna-가이드된 뉴클레아제 및 그의 활성 단편 및 변이체 및 사용 방법 | |
| KR20210127206A (ko) | 유전성 질환의 치료를 위한 것을 포함하는, 아데노신 데아미나제 염기 편집기를 사용하여 질환-관련 유전자를 편집하는 방법 | |
| US20240287453A1 (en) | Persistent allogeneic modified immune cells and methods of use thereof | |
| CN114072509A (zh) | 脱氨反应脱靶减低的核碱基编辑器和使用其修饰核碱基靶序列的方法 | |
| KR20200121782A (ko) | 아데노신 염기 편집제의 용도 | |
| CA3225808A1 (en) | Context-specific adenine base editors and uses thereof | |
| EP4229195A1 (en) | Compositions and methods for treating glycogen storage disease type 1a | |
| JP2024511163A (ja) | アデノシンデアミナーゼバリアント及びその使用 | |
| KR20230145051A (ko) | 아데노바이러스 유전자 치료 벡터 | |
| KR20240012377A (ko) | 염기 편집기의 자기-불활성화용 조성물 및 방법 | |
| CA3189662A1 (en) | Compositions comprising a nuclease and uses thereof | |
| HK40038501A (en) | Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias | |
| HK40038987A (en) | Transposition of nucleic acid constructs into eukaryotic genomes with a transposase from amyelois |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| A201 | Request for examination | ||
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| P22-X000 | Classification modified |
St.27 status event code: A-2-2-P10-P22-nap-X000 |